A Real-world Study of DEXYCU in the Treatment of Inflammation After Cataract Surgery
Clinical trial NCT06497699 · COMPLETED
Trial details
- NCT number
- NCT06497699
- Sponsor
- Ocumension Therapeutics (Shanghai) Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-28
- Primary completion
- 2023-07-08
- Enrollment
- 263
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.